Buy Rating on Context Therapeutics’s CTIM-76 Bolstered by Market Validation and Competitive Edge

15d ago, source: Business Insider

Begin your TipRanks Premium journey today. Context Therapeutics (CNTX) Company Description: Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of ...

Sagimet Biosciences' Denifanstat Imminent Phase 3: A Promising Investment Opportunity

9h ago, source:

Sagimet Biosciences' leading drug candidate, denifanstat, is progressing to phase 3 with successful trial results. Find out ...

Robert Connelly Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) CEO is the most bullish insider, and their stock value gained 11%last week

13d ago, source:

Key Insights Elicio Therapeutics' significant insider ownership suggests inherent interests in company's expansion ...

Hold Rating on Bioxcel Therapeutics Amid Strategic and Clinical Trial Uncertainties

20h ago, source:

Analyst Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Bioxcel Therapeutics (BTAI – Research Report) and keeping ...

Better Buy: Pfizer vs. Viking Therapeutics

on MSN ago, source:

In this match-up, Pfizer arguably stands out as the more attractive investment. The company's stock is less risky, offers a ...

Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain

10d ago, source:

HRTX has received approval for its supplemental New Drug Application for Zynrelef, allowing its use in more surgical ...

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

on MSN ago, source:

The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder ...

Market Whales and Their Recent Bets on VKTX Options

8d ago, source:

An analyst from Oppenheimer has decided to maintain their Outperform rating on Viking Therapeutics, which currently sits at a ...

NRx Pharmaceuticals Unveils Breakthrough Ketamine Formulation for Pain-Free Administration

5d ago, source: MyChesCo on MSN

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), in collaboration with Nephron Pharmaceuticals, has announced the development of a ...

Medpace Holdings, Inc. Reports First Quarter 2024 Results

4d ago, source: Business Wire

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, ...

Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms bore the brunt

6d ago, source:

Key Insights Significant control over Repare Therapeutics by private equity firms implies that the general public ...

Q4 2023 Cognition Therapeutics Inc Earnings Call

1mon ago, source:

Hello, everyone, and welcome to Cognition Therapeutics fourth quarter 2023 earnings call. Please note that this call is being recorded. I'd now like to hand over to our first speaker for today, Mike ...